Substance / Medication

Amobarbital

Overview

Active Ingredient
amobarbital
RxNorm CUI
719

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Research Evidence

Published studies and systematic reviews

Sort:
Intracarotid propofol testing: a comparative study with amobarbital.
Mikati Mohamad A, Naasan Georges, Tarabay Hayssam et al. · Epilepsy Behav · 2009
PMID: 19162226RCT
Advantages of methohexital over amobarbital in determining hemispheric language and memory lateralization in the Wada test - A retrospective study.
Conradi Nadine, Rosenberg Friederike, Biermann Louise et al. · Epilepsy Behav · 2020
PMID: 33246234Observational
Comparing the Intracarotid Amobarbital Test and Functional MRI for the Presurgical Evaluation of Language in Epilepsy.
Massot-Tarrús Andreu, Mousavi Seyed Reza, Mirsattari Seyed M · Curr Neurol Neurosci Rep · 2017
PMID: 28623489Observational
Bilateral Wada test: amobarbital or propofol?
Curot J, Denuelle M, Busigny T et al. · Seizure · 2014
PMID: 24252808Observational
A comparison of propofol and amobarbital for use in the Wada test.
Magee James A, Pender Niall P, Abrahams Sharon et al. · Seizure · 2012
PMID: 22425425Observational
The intracarotid amobarbital or Wada test: unilateral or bilateral?
Uijl S G, Leijten F S S, Arends J B A M et al. · Acta Neurol Scand · 2009
PMID: 18684215Observational
Language assessment in Wada test: comparison of methohexital and amobarbital.
Loddenkemper Tobias, Möddel Gabriel, Dinner Dudley S et al. · Seizure · 2009
PMID: 19800265Observational
Carbonic anhydrase-inhibiting medications and the intracarotid amobarbital procedure in children.
Burns Thomas G, Lee Gregory P, McCormick Megan L et al. · Epilepsy Behav · 2009
PMID: 19208439Observational
The role of the intracarotid amobarbital procedure in predicting verbal memory decline after temporal lobe resection.
Baxendale Sallie, Thompson Pamela, Harkness William et al. · Epilepsia · 2007
PMID: 17346250Observational

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Health Goals

Goals connected through associated conditions

Quick Facts

Type
Substance / Medication
Fully Specified Name
Amobarbital (substance)
SNOMED CT
372831009
UMLS CUI
C0002640
RxNorm CUI
719

Clinical Data

This intervention maps to 7 entities in the Healos knowledge graph.

2
Conditions
1
Biomarkers
2
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.